1 / 35

VASCULAR PURPURAS

VASCULAR PURPURAS. Arial Font. Hemostasis. Haemostasis refers to spontaneous arrest of bleeding caused by injury of small blood vessels . Small vessels are continuously exposed to trauma during normal activities can not bleed due to effects of haemostasis . Hemostasis - Functions.

nanji
Download Presentation

VASCULAR PURPURAS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VASCULAR PURPURAS Arial Font

  2. Hemostasis • Haemostasis refers to spontaneous arrest of bleeding caused by injury of small blood vessels. • Small vessels are continuously exposed to trauma during normal activities can not bleed due to effects of haemostasis.

  3. Hemostasis - Functions • Maintains blood in a fluid, clot free state in normal vessel. • Induce rapid and localized haemostatic plug at the site of injury.

  4. Hemostasis - Mechanism Haemostasis depends on three components • Vascular wall • Platelets • Coagulation cascade

  5. Hemorrhage and its Forms • Hemorrhagerefers to extravasation of blood due to rupture of blood vessels. Haemorrhage may be external or may be enclosed within a tissue. • Hematomameans accumulation of haemorrhagic blood in a tissue. • Petechae is minute 1 to 2 mm haemorrhage into skin, mucous membrane or serous surface.

  6. Hemorrhage and its Forms • Purpura is haemorrhage larger than 3 mm into skin and mucous membrane. • Echymosisis subcutaneous haematoma larger than 2 cm. • Large accumulation of blood in body cavities like pleural cavity, peritoneal cavity, pericardial cavity, synovial cavity are called • haemothorax, • haemoperitoneum, • haemopericardium • haemarthrosis.

  7. Clinical Significance of Hemorrhage • Clinical effects of haemorrhage depend on • volumeand rate of blood loss - rapid removal of up to 20% of blood volume or slow losses of even larger amount may have little impact in healthy adult. Greater losses may result in haemorrhagicshock. • site of haemorrhage is also important. Bleeding that would be insignificant in subcutaneous tissue may cause death if located in the brain because the skull is unyielding and bleeding can result increased intracranial pressure and herniated. • chronicor recurrent external blood loss may lead to iron deficiency anaemia.

  8. Hemorrhagic Disorders Hemorrhagic disorders are a group of disorders of many different causes characterized by an abnormal tendency of bleeding due to failure of hemostasis.

  9. Clinical Character of Hemorrhagic Disorders • Spontaneous bleeding in the skin, mucous membrane or internal tissue. • Extensive or prolonged bleeding following trauma. • Bleeding from more than one site.

  10. Causes of Hemorrhagic Disorders • Due to vascular defects • Due to platelet defects • Due to coagulation defects. • Combination of all

  11. Bleeding due to vascular defects Common characters: • More common but less severe • Usually in the form of petechae or purpura • Increased bleeding time and frequently positive tourniquet test. • Normal platelet count or function. • Normal CT, APTT, PT and TT

  12. Acquired: Simple easy bruising (devil’s pinches) Senile purpura The symptomatic vascular purpura (non-thromcytopenicpurpura) Infection Drugs Uraemia Cushing’s syndrome and adrenocorticosteroid administration Scurvy Dysproteinaemia Henoch-Schoenleinpurpura Miscellaneous Orthostatic purpura Mechanical purpura Fat embolism Auto-erythrocyte sensitization Systemic disorders – collagen diseases, polyarteritisnodusa, amyloidosis, allergy Congenital: Hereditary haemorrhagic telangiectasis (Osler-Rendu-weber disease) Ehlars-danlos disease Vascular Disorders - Classification

  13. Henoch-SchönleinPurpura (HSP)

  14. HSP - Background • HSP is a small-vessel vasculitis characterized by purpura, arthritis, abdominal pain, and hematuria. • It is also known as anaphylactoidpupura. • It is the most common cause of non-thrombocytopenic purpura in children

  15. HSP - Epidemiology • The etiology of HSP is unknown, but it typically follows as upper respiratory tract infection. • It used to account for about 1% of the admissions to hospital but changes in the medical practice have reduced the frequency to about 0.6%. • It is more frequent in children more than adult, and mostly occurs between the ages of 2-8 years.

  16. HSP - Epidemiology • Males are affected twice as frequently as females. • And the overall incidence is estimated to be 9/100000 population

  17. HSP - Etiology • The etiology of HSP is unknown. • About 50% of patients have a preceding upper respiratory illness (URI). • Multiple infectious agents as well as drugs, foods, and insect bites may trigger HSP.

  18. HSP - Pathophysiology • This illness is considered by histopathology to be an IgA mediated vasculitis of small vessels. • And immunoflorescent techniques may show deposition of IgA and C3 in the small vessels of the skin and the renal glomeruli

  19. HSP - Pathophysiology • HSP and IgA nephropathy are related disorders. • Both illnesses have elevated serum IgA levels and identical findings on renal biopsy. • however, IgA nephropathy almost exclusively involves young adults and predominantly affects the kidneys only. • HSP affects mostly children and involves the skin and connective tissues, gastrointestinal tract, joints, and scrotum as well as the kidneys.

  20. HSP - Mortality/Morbidity • In general, HSP is a benign self-limited disorder. • Fewer than 5% of cases cause chronic symptoms. • Fewer than 1% of cases progress to end-stage renal failure. • Sex: Male-to-female ratio is about 2:1. • Age: Seventy-five percent of patients affected are aged 2-8 years.

  21. HSP - History • The onset of the disease maybe acute with the appearance of several manifestations simultaneously, or insidious with sequential occurrence of symptoms over period of weeks to months. • Low grade fever and fatigue occur in more than half of affected children

  22. HSP – Cinical Manifestations • Rash (95-100%), especially involving the legs, may not be present on initial presentation • Beginning as pinkish maculopapules that initially blanches on pressure. • Then progress petechiae or purpura which are characterized clinically as palpable pupura that evolve from red to purple rusty brown before they eventually fade.

  23. HSP – Cinical Manifestations • The lesions tend to occur in crops lasting from 3-10 days and may appear at intervals that vary from a few days to as long as 3-4 months. • In fewer than 10% of children, recurrence of the rash may not end until as late as a year and rarely several years after the initial episode

  24. Purpura

  25. Purpura

  26. HSP – Cinical Manifestations • Subcutaneous edema (20-50%) • Damage to cutanuous vessels also may result in local angiodema, which may preceed the palpable purpura. • Edema occurs primarily in dependent areas, as below the waist, over the buttocks or on the back and posterior scalp of infants, or in areas of greater tissue destisibility such as eyelids, lips, scrotum, or dorsum of the hands or feet.

  27. HSP – Cinical Manifestations • Joint pain (60-80%), especially involving knees and ankles • Arithritis is usually localized to the knees and ankles and appears to be concomitant with edema. • The effusion are serous, not hemorrhagic, in nature and resolve after few days without residual deformity or articular damage. • They may recur during a subsequent reactive phase of the disease

  28. HSP – Cinical Manifestations • Abdominal pain and vomiting (85%) • Edema and damage to the vasculature of the GIT may also lead to intermittent abdominal pain that is often colicky in nature. • More than half of patients have occult positive stools, diarrhea or hematemesis. • The recognition of peritoneal exudates, enlarged mesenteric lymph nodes, segmental edema, and hemorrhage into the bowel may prevent unnecessary laporotomy for acute abdomen. • Intussusception may occur, which is suggested by an empty right lower abdominal quadrant on physical examination or by cuurant jelly stools, which may be followed by complete obstruction or infarction with bowel perforation.

  29. HSP – Cinical Manifestations • Several other organs may be involved during the acute phase of the disease. • Renal involvement occur in 20-50% of patients. • Hepatosplenomegaly and lymphadenopathy may also occur. • A rare but potentially serious outcome of the CNS involvement is the development of seizures, paresis, or coma. • Other rare complications include cardiac and eye involvement, mononeuropathy, pancreatitis and pulmonary or intramuscular hemorrhage

  30. HSP –Physical • Palpable purpura, particularly on the buttocks and legs Edema of the hands, feet, scalp, and ears • Arthritis, most commonly involving the knees and ankles • Abdominal tenderness • Gastrointestinal bleeding • Acute scrotal edema that may mimic testicular torsion

  31. HSP - Lab Studies • Platelet count and coagulation studies: • Platelet count is usually in the reference range but may be elevated; the platelet count should not be low in HSP. • A normal platelet count rules out idiopathic thrombocytopenic purpura (ITP). • A normal platelet count and normal coagulation studies (ie, PT, aPTT, fibrin split products) rule out thrombotic thrombocytopenic purpura (TTP). • Lipase: A normal lipase makes acute pancreatitis very unlikely.

  32. HSP - Lab Studies • CBC and differential: WBC count may be in the reference range or elevated. Eosinophilia is sometimes present. • Erythrocyte sedimentation rate: Sedimentation rate may be in the reference range or elevated. • BUN and creatinine levels: These may be elevated from renal involvement of HSP or from dehydration. • Urinalysis: Hematuria and/or proteinuria are present in 10-20% of patients.

  33. Definitive diagnosis of vasculitis, confirmed by biopsy of an involved cutanuous site, shows leuckocytoclasticangiits. • Renal biopsy may show IgAmesengial deposition and occasionally IgM,C3, and fibrin.

  34. HSP - Medications • Nonsteroidal anti-inflammatory drugs (NSAIDs) may help joint pain and do not worsen the purpura. However, NSAIDs should be used cautiously in patients with renal insufficiency. • Clinicians often use corticosteroids to treat abdominal pain, subcutaneous edema, and nephritis, but no prospective, placebo-controlled studies have demonstrated their effectiveness. Most patients recover quickly without treatment.

  35. HSP - Medications • Treatment in patients with severe HSP nephritis includes many different modalities, but again, no prospective controlled studies prove the efficacy of any of these treatments. • Treatment regimens have included IV or oral steroids with or without any of the following: azathioprine, cyclophosphamide, cyclosporine, high-dose IV immunoglobulin G (IVIg), danazol, or fish oil.

More Related